Portfolio Manager Factsheet

March 2019

After significant declines in volatility in both January and February, March bore witness to some renewed market turbulence, nevertheless, equities rallied in the back half of March. We participated in an IPO as a cornerstone investor of China-based CanSino Biologics a leader in premium vaccines for the local private pay market. The IPO was very well received and traded up 60% on the first day of trading in Hong Kong. 

Read more »

Worldwide Healthcare Trust PLC conducts its affairs so that its shares can be recommended by independent financial advisers (IFAs) to retail private investors. The shares are excluded from the Financial Conduct Authority's (FCA's) restrictions which apply to non-mainstream investment products because they are shares in a UK-listed investment trust.